SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-040291
Filing Date
2013-05-10
Accepted
2013-05-10 16:16:42
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a13-8338_110q.htm 10-Q 718407
2 EX-31.1 a13-8338_1ex31d1.htm EX-31.1 10211
3 EX-31.2 a13-8338_1ex31d2.htm EX-31.2 10102
4 EX-32.1 a13-8338_1ex32d1.htm EX-32.1 5574
5 EX-32.2 a13-8338_1ex32d2.htm EX-32.2 5624
  Complete submission text file 0001104659-13-040291.txt   4811537

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bpax-20130331.xml EX-101.INS 320799
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bpax-20130331.xsd EX-101.SCH 79647
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bpax-20130331_cal.xml EX-101.CAL 25024
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bpax-20130331_def.xml EX-101.DEF 385649
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bpax-20130331_lab.xml EX-101.LAB 1176004
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bpax-20130331_pre.xml EX-101.PRE 553122
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 13833663
SIC: 2836 Biological Products, (No Diagnostic Substances)